Literature DB >> 30858576

Moving upstream in anticancer drug development.

William N Hait, Peter F Lebowitz.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 30858576     DOI: 10.1038/d41573-018-00006-3

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

1.  Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression.

Authors:  Xu Cao; Yingyu Wang; Wencan Zhang; Xiancai Zhong; E Gulsen Gunes; Jessica Dang; Jinhui Wang; Alan L Epstein; Christiane Querfeld; Zuoming Sun; Steven T Rosen; Mingye Feng
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

2.  Anticancer activity and QSAR study of sulfur-containing thiourea and sulfonamide derivatives.

Authors:  Ratchanok Pingaew; Veda Prachayasittikul; Apilak Worachartcheewan; Anusit Thongnum; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Heliyon       Date:  2022-08-02

3.  Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.

Authors:  Alastair F Breen; David Scurr; Maria Letizia Cassioli; Geoffrey Wells; Neil R Thomas; Jihong Zhang; Lyudmila Turyanska; Tracey D Bradshaw
Journal:  Int J Nanomedicine       Date:  2019-12-05

Review 4.  Mechanism of activation and the rewired network: New drug design concepts.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Chung-Jung Tsai; Bengi Ruken Yavuz; Nurcan Tuncbag; Hyunbum Jang
Journal:  Med Res Rev       Date:  2021-10-25       Impact factor: 12.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.